Search results
Results From The WOW.Com Content Network
In pharmacokinetics, the rate of infusion (or dosing rate) refers not just to the rate at which a drug is administered, but the desired rate at which a drug should be administered to achieve a steady state of a fixed dose which has been demonstrated to be therapeutically effective. Abbreviations include K in, [1] K 0, [2] or R 0.
A 1977 article compares the "classical" trapezoidal method to a number of methods that take into account the typical shape of the concentration plot, caused by first-order kinetics. [ 8 ] Notwithstanding the above knowledge, a 1994 Diabetes Care article by Mary M. Tai purports to have independently discovered the trapezoidal rule. [ 9 ]
The accumulation ratio of a specific drug in humans is determined by clinical studies. According to a 2013 analysis, such studies are typically done with 10 to 20 subjects who are given one single dose followed by a washout phase of seven days , and then seven to 14 repeated doses to reach steady state conditions. Blood samples are drawn 11 ...
Q is the urine flow (volume/time) [mL/min] (often [mL/24 h]) C B is the plasma concentration [mmol/L] (in the USA often [mg/mL]) When the substance "C" is creatinine, an endogenous chemical that is excreted only by filtration, the clearance is an approximation of the glomerular filtration rate .
This gives a = 100 μg/mL if the drug stays in the blood stream only, and thus its volume of distribution is the same as that is = 0.08 L/kg. If the drug distributes into all body water the volume of distribution would increase to approximately V D = {\displaystyle V_{D}=} 0.57 L/kg [ 8 ]
The elimination rate constant K or K e is a value used in pharmacokinetics to describe the rate at which a drug is removed from the human system. [1] It is often abbreviated K or K e. It is equivalent to the fraction of a substance that is removed per unit time measured at any particular instant and has units of T −1.
The formula for calculating the absolute bioavailability, F, of a drug administered orally (po) is given below (where D is dose administered). F a b s = 100 ⋅ A U C p o ⋅ D i v A U C i v ⋅ D p o {\displaystyle F_{\mathrm {abs} }=100\cdot {\frac {AUC_{\mathrm {po} }\cdot D_{\mathrm {iv} }}{AUC_{\mathrm {iv} }\cdot D_{\mathrm {po} }}}}
One computational method which can be used to calculate IV estimates is two-stage least squares (2SLS or TSLS). In the first stage, each explanatory variable that is an endogenous covariate in the equation of interest is regressed on all of the exogenous variables in the model, including both exogenous covariates in the equation of interest and ...